home / stock / mnkd / mnkd short
Short Information | MannKind Corporation (NASDAQ:MNKD)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 7,872,368 |
Total Actual Volume | 54,372,551 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 393,618 |
Average Short Percentage | 14.98% |
Is there a MNKD Short Squeeze or Breakout about to happen?
See the MNKD Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-05-2024 | $5.02 | $5.13 | $5.14 | $4.92 | 1,629,624 | 238,862 | 14.66% |
07-03-2024 | $5.05 | $5.03 | $5.235 | $4.99 | 876,585 | 134,305 | 15.32% |
07-02-2024 | $5.06 | $5.03 | $5.08 | $4.95 | 1,839,509 | 221,862 | 12.06% |
07-01-2024 | $5.2 | $5.09 | $5.27 | $5.01 | 3,040,165 | 579,030 | 19.05% |
06-28-2024 | $5.3823 | $5.22 | $5.39 | $5.115 | 5,349,644 | 157,311 | 2.94% |
06-27-2024 | $5.22 | $5.29 | $5.3 | $5.175 | 1,490,708 | 211,586 | 14.19% |
06-26-2024 | $5.24 | $5.19 | $5.265 | $5.15 | 2,095,400 | 452,473 | 21.59% |
06-25-2024 | $5.37 | $5.24 | $5.51 | $5.225 | 2,791,845 | 397,067 | 14.22% |
06-24-2024 | $5.15 | $5.43 | $5.55 | $5.0858 | 5,539,258 | 1,429,870 | 25.81% |
06-21-2024 | $4.9 | $5.11 | $5.14 | $4.87 | 7,078,841 | 513,128 | 7.25% |
06-20-2024 | $4.8 | $4.86 | $4.975 | $4.75 | 2,188,445 | 392,740 | 17.95% |
06-18-2024 | $4.76 | $4.78 | $4.8193 | $4.72 | 1,922,537 | 214,422 | 11.15% |
06-17-2024 | $4.75 | $4.75 | $4.785 | $4.62 | 2,432,966 | 477,540 | 19.63% |
06-14-2024 | $5 | $4.8 | $5.01 | $4.74 | 2,691,024 | 492,743 | 18.31% |
06-13-2024 | $4.73 | $5.04 | $5.13 | $4.71 | 3,467,882 | 535,547 | 15.44% |
06-12-2024 | $4.7 | $4.73 | $4.8 | $4.69 | 2,308,105 | 236,488 | 10.25% |
06-11-2024 | $4.43 | $4.65 | $4.66 | $4.42 | 1,583,703 | 247,977 | 15.66% |
06-10-2024 | $4.58 | $4.49 | $4.6 | $4.36 | 3,202,289 | 581,311 | 18.15% |
06-07-2024 | $4.62 | $4.67 | $4.78 | $4.57 | 1,722,064 | 190,520 | 11.06% |
06-06-2024 | $4.69 | $4.645 | $4.75 | $4.635 | 1,121,957 | 167,586 | 14.94% |
News, Short Squeeze, Breakout and More Instantly...
Study proves inhaled insulin is as effective as usual care (primarily automated insulin delivery pumps or multiple daily injections) for adults living with T1D meeting the primary endpoint Patients utilizing inhaled insulin reached target A1c (less than 7%) 30% of the time compared to 17%...
17-week endpoint results comparing Afrezza ® head-to-head with multiple daily injections (MDI) and insulin pumps INHALE-3 Study Protocol Chair Dr. Irl. B. Hirsh joined by investigational team to deliver presentation moderated by Jaeb Center founder Dr. Roy W. Beck ...
Pulmatrix Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation PR Newswire Cross license involves Pulmatrix iSPERSE™ technology and MannKind's Cricket ® inhalation device. Pulmatrix transferring leased building,...